Skip to main content
Caplight Logo









May Health

May Health

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://mayhealth.com/

Last Round

VC Round

Mar 10, 2026

Total Funding Raised

$36.23M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

May Health is a medical device company that develops innovative ablation technology to restore ovulation in women suffering from PCOS-related infertility.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicePCOS treatmentovarian rebalancingfertility treatmentmedtechradiofrequency ablationreproductive endocrinologywomen's healthclinical trialsfertility techPCOSinfertility solutionsFDA clearancefemtechminimally invasive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

May Health Comparables

Compare May Health with similar companies based on industry and business-model similarity.

May Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Femasys Inc.
66%
The Cooper Companies
64%
Merck
59%

May Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 10, 2026
Series BMay 13, 2024
Series AJul 9, 2019
GrantJul 12, 2018

Key People

Founding team and executive leadership

Hugh Magen

Chief Technology Officer

Executive Team

May Health Investors

Notable investors and investment history

May Health investors
InvestorRounds
MedTech InnovatorGrant
Trill ImpactVC Round, Series B
Kidron CapitalSeries B
Avestria VenturesSeries B
Sofinnova PartnersSeries B, VC Round, Series A
BpifranceVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2027

    Limited European launch of Anavi System planned for 2027.

  • Apr 1, 2026

    Achieved CE Mark for its Anavi System.

May Health Filings

Explore SEC and related filing metadata, where available.

May Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about May Health's valuation, stock price, and market status.

Is May Health a public or private company?

May Health is a private company.

What is the current stock price of May Health?

May Health is a private company with no public stock price. No recent secondary market data is available.

How much is May Health worth (valuation)?

Valuation information for May Health is not publicly available.

Can I buy May Health stock?

May Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was May Health's last funding round?

May Health's most recent funding round was Early Funding on March 10, 2026.

Who are the main investors in May Health?

Key investors in May Health include Trill Impact, Bpifrance, Sofinnova Partners.

Will May Health IPO soon?

No public IPO plans have been announced for May Health.

How can I track May Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor May Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range21
Year Founded2014
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?